日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Composition-Controlled Cathode Protective Layer via Powder-Atomic Layer Deposition for All-Solid-State Batteries

利用粉末原子层沉积法制备成分可控的全固态电池正极保护层

Kwon, Kyu Moon; Kim, Dae Ho; Kwon, Ha Yeon; Park, Joungwon; Kim, Kyoung Hwan; Park, Hwi-Yeol; Kang, Hyo Rang; Park, Tae Joo

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

RET 改变实体瘤中选择性 RET 抑制剂耐药的基因组机制图谱:RETregistry 全球联盟分析

Waliany, Sarah; Cooper, Alissa J; Liu, Stephen V; Gautschi, Oliver; Rotow, Julia K; Smith, Katherine Emilie Rhoades; Weber, Urs M; Lee, Dae Ho; Loong, Herbert H F; Patel, Jyoti D; Pennell, Nathan A; Nagasaka, Misako; Patel, Shetal A; Tan, Daniel S W; Solomon, Benjamin J; Kim, Tae Min; Pall, Georg; Riess, Jonathan W; Sun, Lova; Früh, Martin; Uy, Natalie F; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B; Baik, Christina S; Lai, Gillianne G Y; Ou, S Ignatius; Cheung, Kingsley S Y; Patil, Tejas; Mansfield, Aaron S; Weiler, Daniela; Yeap, Beow Y; Wirth, Lori J; Gainor, Justin F; Drilon, Alexander; Lin, Jessica J

Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects

肥胖患者袖状胃切除术后动态脂质组重塑及临床相关性

Lee, Gakyung; Lee, Yeong Chan; Park, Minkuk; Kim, Seong Min; Park, Ji-Hyeon; Lee, Dae Ho

Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancer

韩国非小细胞肺癌患者EGFR 20号外显子插入的分子流行病学及预后

Yoon, Shinkyo; Kim, Seong-Eun; Lim, Sun Min; Jung, Hyun Ae; Kim, Kyu-Pyo; Kim, Dong-Kyu; Jeong, Hyehyun; Lim, Subin; Kim, Jung-Ae; Kim, Joohyun; Patel, Dony; Zhao, Xiahong; Yu, Dae Young; Kim, Ji Hyun; Lee, Dae Ho

Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications

代谢功能障碍相关脂肪肝疾病中的肝脏胰岛素抵抗和脂肪变性:机制和临床意义的新见解

Truong, Xuan Trong; Lee, Dae Ho

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines.

MED12 突变通过炎症细胞因子激活 MEK/ERK 通路,诱导 NSCLC 对 RTK 抑制剂产生耐药性

Ryu Hyun-Min, Kim Deokhoon, Choi Jun Young, Yoon Shinkyo, Lee Ho-Su, Park Ji Eun, Lee Eunjin, Sung Yunkyung, Lee Chang Hoon, Lee Eun-Young, Kim Wanlim, Seo Seyoung, Kim Sang-We, Park Kang-Seo, Lee Dae Ho

Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison

根据PD-L1表达水平分层评估一线纳武利尤单抗联合化疗治疗晚期胃癌的疗效:一项真实世界研究的比较

Choi, Dae-Ho; Shin, Ji Eun; Lee, Eunbyeol; Kim, Seung Tae; Lim, Sung Hee

Epidermal Growth Factor Receptor Aberrations Identified by Next-Generation Sequencing in Patients with Metastatic Cancers

利用新一代测序技术在转移性癌症患者中发现表皮生长因子受体异常

Shin, Minkyue; Choi, Dae-Ho; Jung, Jaeyun; Kim, Deok Geun; An, Minae; Lim, Sung Hee; Kim, Seung Tae; Hong, Jung Yong; Park, Se Hoon; Park, Joon Oh; Kim, Kyoung-Mee; Lee, Jeeyun

Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinib

通过治疗前NGS检测发现的TP53外显子水平改变和PD-L1表达可对接受一线奥希替尼治疗的EGFR突变型非小细胞肺癌患者的生存期进行分层。

Kim, Seong-Eun; Kim, Yongjae; Yoon, Do Kyung; Park, Hwan; Park, Kang-Seo; Kim, Deokhoon; Hwang, Hee Sang; Ahn, Bokyung; Park, Ji Eun; Kim, Sang-We; Jang, Se Jin; Yoon, Shinkyo; Lee, Ho-Su; Lee, Dae Ho

First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With RET Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup Analysis

一线治疗RET融合阳性非小细胞肺癌患者(来自东亚):Selpercatinib或化疗联合Pembrolizumab:LIBRETTO-431亚组分析

Goto, Koichi; Loong, Herbert H; Zhou, Caicun; Nishino, Kazumi; Lee, Dae Ho; Lee, Se-Hoon; Chih-Hsin Yang, James; Liu, Dan; Uh, Minji Kim; Han, Hongmei; Puri, Tarun; Lin, Aimee Bence; Cheng, Ying